Patents by Inventor James Whyte Black

James Whyte Black has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions comprising proton pump inhibitors and gastrin/cholecystokinin receptor ligands
    Publication number: 20030195240
    Abstract: Pharmaceutical compositions comprising a proton pump inhibitor and a compound of the formula (I) or its pharmaceutically acceptable salts, are useful in treating gastrointestinal disorders.
    Type: Application
    Filed: April 14, 2003
    Publication date: October 16, 2003
    Inventors: Sarkis Barret Kalindjian, James Whyte Black, Robert Anthony David Hull, Nigel Paul Shankley, Jean Louis Mesens, Luc Joseph Andries
  • Gastrin and cholecystokinin receptor ligands
    Patent number: 6479531
    Abstract: Compounds of formula (I) and their pharmaceutically acceptable salts are ligands at gastrin and/or cholecystokinin receptors. X and Y are independently ═N—, —N(R5)—═CH—, —S— or —O—.
    Type: Grant
    Filed: August 2, 2001
    Date of Patent: November 12, 2002
    Assignee: James Black Foundation Limited
    Inventors: Sarkis Barret Kalindjian, Ildiko Maria Buck, Ian Duncan Linney, Paul Trevor Wright, Iain Mair McDonald, Katherine Isobel Mary Steel, Robert Antony David Hull, Sonia Patricia Roberts, John David Gaffen, Jeremy Gilbert Vinter, Martin Keith Walker, James Whyte Black, Gillian Fairfull Watt, Elaine Anne Harper, Nigel Paul Shankley, Matthew John Tozer, David John Dunstone, Michael John Pether, Elliot James Lilley, David Andrew Sykes, Caroline Minli Rachel Low, Eric Peter Griffin, Laurence Wright
  • Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors
    Patent number: 4104382
    Abstract: Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors by administering an antihistamine and an H-2 histamine receptor inhibitor. Exemplary of the antihistamine in the compositions and methods of this invention is mepyramine and exemplary of the H-2 histamine receptor inhibitor is N-cyano-N'-methyl-N"-[2-((4-methyl-5-imidazolyl)-methylthio)ethyl]guanidin e.
    Type: Grant
    Filed: September 27, 1976
    Date of Patent: August 1, 1978
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: James Whyte Black, Michael Edward Parsons
  • Method of inhibiting histamine activity with quanidine compounds
    Patent number: 4048319
    Abstract: A method of inhibiting histamine activity, in particular inhibiting H-2 histamine receptors, by administering heterocyclicalkylguanidines.
    Type: Grant
    Filed: March 19, 1976
    Date of Patent: September 13, 1977
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: James Whyte Black, Graham John Durant, John Colin Emmett, Charon Robin Ganellin
  • Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors
    Patent number: 4000302
    Abstract: Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors by administering an antihistamine and an H-2 histamine receptor inhibitor. Exemplary of the antihistamine in the compositions and methods of this invention is mepyramine and exemplary of the H-2 histamine receptor inhibitor is N-cyano-N'-methyl-N"-[2-((4-methyl-5-imidazolyl)-methylthio)ethyl]guanidin e.
    Type: Grant
    Filed: April 16, 1975
    Date of Patent: December 28, 1976
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: James Whyte Black, Michael Edward Parsons
  • Method of inhibiting histamine activity with guanidine compounds
    Patent number: 3968216
    Abstract: A method of inhibiting histamine activity in particular inhibiting H-2 histamine receptors, by administering heterocyclicalkylguanidines.
    Type: Grant
    Filed: November 25, 1974
    Date of Patent: July 6, 1976
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: James Whyte Black, Graham John Durant, John Colin Emmett, Charon Robin Ganellin
  • Pharmaceutical compositions and method of inhibiting H-1 and H-2 histamine receptors
    Patent number: 3954982
    Abstract: Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors by administering an antihistamine and an H-2 histamine receptor inhibitor. Exemplary of the antihistamine in the compositions and methods of this invention is mepyramine and exemplary of the H-2 histamine receptor inhibitor is N-methyl-N'-[4-(5)-imidazolyl)butyl]thiourea.
    Type: Grant
    Filed: April 16, 1975
    Date of Patent: May 4, 1976
    Assignee: Smith Kline & French Laboratories Limited
    Inventors: James Whyte Black, Michael Edward Parsons